RAFAEL HOLDINGS, INC. Notes Payable
RAFAEL HOLDINGS, INC. (RFL) had Notes Payable of $87.00 million as of 2022-08-22, per its 10-Q filed 2023-06-13.
Discontinued › Balance Sheet › Liabilities › Long-Term Debt, Unclassified › Notes Payable
us-gaap:NotesPayable · last filed 2023-06-13
- 2022-08-22: Notes Payable $87.00M.
- 2021-07-09: Notes Payable $15.00M.
| Period end | Notes Payable |
|---|---|
| 2022-08-22 | $87.00M 10-Q · filed 2023-06-13 |
| 2021-07-09 | $15.00M 10-Q · filed 2023-06-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |